We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tesla (TSLA - Free Report) shares rallied strongly to the news that the company was within shouting distance of a 100,000 vehicle delivery milestone.
The eccentric CEO Elon Musk who has been criticized by analysts, market watchers and law enforcement, is in the habit of charging up his employees before quarter-end. That’s what his email was supposed to be doing, when it said,
“We have a shot at achieving our first 100,000 vehicle delivery quarters…Net orders are tracking to reach about 110k, so demand is strong.”
The email somehow leaked out and the contents picked up by EV-focused news website Electrek. If Tesla hits that mark, it will be an encouraging sign, increasing the chances of its reaching the deliveries originally targeted.
The original target was to deliver 360,000 to 400,000 vehicles this year. But the company managed just 63,000 in the first quarter, increasing it to 95,200 in the second. If third and fourth quarters come in at 100,000 each, it will be 358,000, or at around the low end of the guided range.
And if fourth-quarter deliveries improve upon the third quarter levels, the company would have silenced most everyone. Because practically no one thought they’d match guidance.
As the email said, right now, “The challenge is making sure that we have the right car variants in the right locations and rallying as much of our company resources as possible to help with end of quarter deliveries.”
Musk did say that demand for the vehicles remains strong, but investors expect a large chunk of that to come from China because of the country’s initiative to boost EV adoption and the brand’s popularity there.
Tesla’s Chinese factory is expected to produce 3,000 Model 3 EVs by the end of the year. Musk said in August that building progress at its Shanghai factory was “mind blowing” and that he has never seen anything like it. So once that comes online, there will be more cars that are also closer to the market to which it’s selling, which should therefore accelerate deliveries.
Tesla continues to make losses, but the key to profitability is stepping up sales. Since that part is going well, I feel incrementally positive about the company.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Tesla Has a Shot at 100,000 Vehicles This Quarter
Tesla (TSLA - Free Report) shares rallied strongly to the news that the company was within shouting distance of a 100,000 vehicle delivery milestone.
The eccentric CEO Elon Musk who has been criticized by analysts, market watchers and law enforcement, is in the habit of charging up his employees before quarter-end. That’s what his email was supposed to be doing, when it said,
“We have a shot at achieving our first 100,000 vehicle delivery quarters…Net orders are tracking to reach about 110k, so demand is strong.”
The email somehow leaked out and the contents picked up by EV-focused news website Electrek. If Tesla hits that mark, it will be an encouraging sign, increasing the chances of its reaching the deliveries originally targeted.
The original target was to deliver 360,000 to 400,000 vehicles this year. But the company managed just 63,000 in the first quarter, increasing it to 95,200 in the second. If third and fourth quarters come in at 100,000 each, it will be 358,000, or at around the low end of the guided range.
And if fourth-quarter deliveries improve upon the third quarter levels, the company would have silenced most everyone. Because practically no one thought they’d match guidance.
As the email said, right now, “The challenge is making sure that we have the right car variants in the right locations and rallying as much of our company resources as possible to help with end of quarter deliveries.”
Musk did say that demand for the vehicles remains strong, but investors expect a large chunk of that to come from China because of the country’s initiative to boost EV adoption and the brand’s popularity there.
Tesla’s Chinese factory is expected to produce 3,000 Model 3 EVs by the end of the year. Musk said in August that building progress at its Shanghai factory was “mind blowing” and that he has never seen anything like it. So once that comes online, there will be more cars that are also closer to the market to which it’s selling, which should therefore accelerate deliveries.
Tesla continues to make losses, but the key to profitability is stepping up sales. Since that part is going well, I feel incrementally positive about the company.
Tesla shares carry a Zacks Rank #3 (Hold). Industry players worth buying instead are IAA, Inc. , Ford Motor Company (F - Free Report) , Fox Factory Holding Corp. (FOXF - Free Report) and General Motors Company (GM - Free Report) . Or see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>